top of page

It Started With A Problem

Brain cancer is a complex and deadly disease; treatment decisions rely on interpreting multiple tumor characteristics and changes on MRIs throughout the care process.  Dr. Aly Abayazeed, our Co-Founder, Chief Medical Officer, and a practicing Neuroradiologist, was searching for a more insightful, empirical and consistent method to analyze brain tumor MRIs to help make the best quality treatment decisions for his patients.

​

Seeing no clinically-available products, the solution was to build a new platform tailored to treating teams to address these issues, and many more.

​

And thus began the Neosoma story...

Filter Team:

Ken Kolodziej

Ken Kolodziej

Co-Founder and Chief Executive Officer

Mauricio Reyes, PhD

Mauricio Reyes, PhD

AI Development

Michael Müller

Michael Müller

AI Development

Arlen Meyers, MD MBA

Arlen Meyers, MD MBA

Strategic Advisor

Nicklaus Khan, MD

Nicklaus Khan, MD

Medical Advisor

Aly Abayazeed, MD

Aly Abayazeed, MD

Co-Founder and Chief Medical Officer

Benjamin Ellingson, PhD

Benjamin Ellingson, PhD

Scientific Advisor: R&D

Jerrold Boxerman, MD

Jerrold Boxerman, MD

Medical Advisor

Ahmed Abbassy, MD

Ahmed Abbassy, MD

AI Development

John Liedtky

John Liedtky

Chief Strategy and Commercial Officer

Golnaz Moeini

Golnaz Moeini

Regulatory

Kambiz Nael, MD

Kambiz Nael, MD

Medical Advisor

Roger Stupp, MD

Roger Stupp, MD

Medical Advisor

Michael Hill

Michael Hill

Chief Technical Officer

Katherine Kacena, PhD

Katherine Kacena, PhD

Biostatistics

Richard Stark

Richard Stark

Strategic Advisor

Ashley Ghiaseddin, MD

Ashley Ghiaseddin, MD

Medical Advisor

Transform Your Neuro-Oncology Practice

bottom of page